Company Telesis Bio, Inc.

Equities

TBIO

US1920031010

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.3184 ^USD	-0.93%		+3.04%	-20.20%

Apr. 18	Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors	CI
Apr. 18	Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	CI

Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The Company provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.

Number of employees: 142

USD in Million	2022	Weight	2023	Weight	Delta
Collaboration 31.6 %	7	24.2 %	9	31.6 %	+30.68%
BioXP Systems 23.8 %	7	24.3 %	7	23.8 %	-1.57%
Services 22.7 %	8	29.5 %	6	22.7 %	-23.08%
BioXP Kits 11.6 %	3	10.7 %	3	11.6 %	+8.48%
Royalties and Other 10.3 %	3	10.0 %	3	10.3 %	+3.13%

USD in Million	2022	Weight	2023	Weight	Delta
North America 77.0 %	8	72.0 %	12	77.0 %	+56.62%
Europe/ Middle East/ Africa 14.0 %	2	14.0 %	2	14.0 %	+46.45%
Asia Pacific 9.0 %	2	14.0 %	1	9.0 %	-5.85%

Managers	Title	Age	Since
Daniel Gibson FOU	Founder	47	11-03-23
Eric Esser CEO	Chief Executive Officer	54	22-04-30
William Kullback DFI	Director of Finance/CFO	64	23-08-27
Todd Nelson BRD	Director/Board Member	57	18-06-30
Jen Carroll IRC	Investor Relations Contact	-	22-11-30
Robert Cutler LAW	General Counsel	56	21-07-31

Members of the board	Title	Age	Since
Jami Nachtsheim BRD	Director/Board Member	65	21-05-31
Christine Tsingos BRD	Director/Board Member	65	21-04-30
Gregory Herrema BRD	Director/Board Member	58	23-10-17
Frank R. Witney Witney CHM	Chairman	70	20-11-30
Todd Nelson BRD	Director/Board Member	57	18-06-30
Eric Esser CEO	Chief Executive Officer	54	22-04-30
Annette Tumolo BRD	Director/Board Member	69	22-07-19
Andrea Jackson BRD	Director/Board Member	45	21-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	30,103,284	18,761,334 ( 62.32 %)	0	62.32 %
Stock B	0	280,000	0	0

Name	Equities	%	Valuation
Northpond Ventures LLC 32.83 %	9,844,130	32.83 %	4 M $
Gattaca Mining LLC 20.42 %	6,122,516	20.42 %	3 M $
BroadOak Capital Partners LLC 7.734 %	2,319,045	7.734 %	1 M $
DANAHER CORPORATION 7.651 %	2,294,157	7.651 %	1 M $
Vanguard Group, Inc. (Subfiler) 1.395 %	418,293	1.395 %	184 049 $
Millennium Management LLC 0.9923 %	297,524	0.9923 %	130 911 $
Abaris Investment Management AG 0.7504 %	225,000	0.7504 %	99 000 $
Todd Nelson 0.5811 %	174,240	0.5811 %	76 666 $
Gregory Herrema 0.5109 %	153,191	0.5109 %	67 404 $
Eric Eugene Esser 0.4311 %	129,260	0.4311 %	56 874 $

Name	Equities	%	Valuation
Novalis Lifesciences LLC 88.39 %	6,558,625	88.39 %	3 M $
Northpond Ventures LLC 1.078 %	80,000	1.078 %	35 200 $

Telesis Bio, Inc.

10431 Wateridge Circle Suite 150

92121-2993, San Diego

http://telesisbio.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3184

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
TELESIS BIO, INC.	-20.20%	9.58M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology